ArticleMagnetic resonance in medicine2026
GABA+-Edited Magnetic Resonance Spectroscopy Deep Learning Quality Assessment Framework.
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeMotivated by the need to improve GABA+-edited magnetic resonance spectroscopy (MRS) quality, we developed a three-module framework to improve transient averaging based on quality. We hypothesized that training a deep learning (DL) model to differentiate spectrum quality could improve transient averaging compared to traditional averaging (simple arithmetic known as Equal-weighting) and an existing software weighting algorithm (MSE-weighting).
methodsThe transient averaging framework was approached through three modules: (1) a continuous-valued automated quality labeling algorithm using both traditional and recently developed MRS quality metrics, (2) a dual-domain (time and frequency) DL model that learns from these quality labels to assess quality scores for new data, and (3) a transient weighting algorithm informed by DL quality scores. The labeling algorithm was used to produce quality labels focused on retaining GABA+ peak shape in difference spectra (1) to train the DL model (2). The DL model quality scores were used to assign weights (3) for transient pairs within the final average difference spectrum. Results were compared to MSE-weighting and Equal-weighting.
resultsRetaining only GABA+-edited transient pairs with positive quality labels resulted in improved spectral quality as assessed using traditional metrics, recently developed metrics and visual assessment of GABA+ and Glx peaks. Applying the trained DL model to in vivo scans improved the fit quality (lower fit error) compared to Equal-weighting (4.759 ± 1.545 vs. 4.877 ± 1.762) and produced higher SNR compared to MSE-weighting (18.758 ± 2.392 vs. 18.004 ± 2.68).
conclusionThe framework as proposed can moderately improve data quality by optimizing transient averaging and provides opportunties for new work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.